reduce the generalizability of any derived predictive model. Second, our model was constructed on the basis of an ICD code specific to wild-type ATTR-CM. This diagnostic code is relatively new and may not be used universally; thus, biases could have been introduced by individual, institutional,...
htaihwsevpsehKimaoeprdnenieicdnrsrTfpototCoemhrcDmebotrinNlenaaadAdrcnsao4ro2artc.mornoTegomeoseipltafphou(re1nertr0trdiaht μAniienvMgrβege e4)bt2vi3oinf3ani.pdlbduRriricaoientalbmlegtaeihrnaeTixraggkCpghaageabarmrnieflmyfdugi,nacetctihhnhteyetsah.noociTgfgurhhTerDeserCerNconotbbAotm...
ICD9/10 codes were used as proxies to identify wtATTR-CM patients on inpatient/outpatient claims within 卤6 months of hospitalization. Within a cohort matched 1:1 by age and sex, univariable logistic regression was used to evaluate relationships between each of the 11 factors of the established...
We extracted a cohort of patients with a diagnosis of CAA using ICD 10 code. Age was categorized as <50 years, 50-59, 60-69, 70-79, and 鈮 80 years. Weighted analysis using chi-square and multivariable survey logistic regression was performed to identify the prevalence of CAA and ...
The study exposure was a diagnosis of CAA identified using ICD-10-CM code I68.0. The primary outcome was seizure, defined using previously validated ICD-10-CM code G40.x, but excluding diagnosis codes for epileptic conditions that are unlikely to be a result of CAA. Participants with ...
H4.eaHt ematapmoafpGOof bGioOlogbiicoallopgircoaclespsreoscienssweshiicnh pwohtiecnhtiaplolyteanmtiayllloyidaomgyelnoiicdpogroetneiicnspproretedinicsted bypWreadlitczteadrebyovWerarletzpraereseonvteerdr.epFroersesnutcehd.pFroortesiuncsh, tphreotteoinps,3t0hGe Otopte3r0mGsOfrotemrmtshefrom...
(aCndDRD3e)s Aofb 3a4 -s4i0n, gwleh‐icdhomtaraginet atnhetibreogdioyn ssca18ff–o2l4da, nasd d3e4s–c4r0iboefdA pβr4e0,vrieosupselcyt i[v1e8ly,3. 7]. ThWesee afinrtsitb oindvieesswtigeraetegden tehrea teedffebcyt gorfa ft...
preyoesrsistauibabltislieensagcvpuiinorreusistfsisobgrilnletyihtcceiouamplrerdooefdtoveirefiniltcoha(peRtmioVmenGono2dt.f9ifiT)dchiwsaeeataissostrnueasstoee[fd2g]dy.tioAfsoetr2aa9srAgeaβsemt[c2itlnh]e.oaer-Abaacrn2aicd9ienpaisamenpaidntniodato-ecatcivide enhapnecpetitdheedneeruivroendaf...
aWs empoorsetulsaetveedrethabtehpaavrtioiarlaleNdOefSicditesficainedncyinwcroeuasldedexAacβerbloaatde thine pthheenbortyaipne oinf APPP//PPSS11/emNicOeS, +s/u− cmh iacse.mTohreesepvrersenbtehsatuvdioyracl hdaerfiaccittesraizneddinAcrPePa/sPeSd1A/eβNlOoaSd+/−inmthiceebarat in8 ...
The low dose of 0.4 mg/kg revealed peak concentration of 10 nM GAL-201 in ISF, which is consistent with dose proportionality. The elimination half-life of GAL-201 from ISF is in the range of 2 h. Since GAL-201 (10 nM) has been shown in the LTP experiments to be efficacious, the ...